Italian National Institute of Health, Rome, Italy; University of Padua, Italy.
Italian National Institute of Health, Rome, Italy.
Vaccine. 2023 Feb 10;41(7):1286-1289. doi: 10.1016/j.vaccine.2023.01.021. Epub 2023 Jan 13.
From January 2020 to July 2022, 120 measles cases were reported to the Italian national surveillance system, of which 105 had symptom onset in 2020, nine in 2021 and six in the first seven months of 2022. This represents a sharp decline compared to the time period immediately preceding the COVID-19 pandemic, most likely due to the non-pharmaceutical interventions implemented to prevent SARS-CoV2 transmission. Of 105 cases reported in 2020, 103 acquired the infection before a national lockdown was instituted on 9 March 2020. Overall, one quarter of cases reported at least one complication. As non-pharmaceutical pandemic measures are being eased worldwide, and considering measles seasonality, infectiousness, and its potential severity, it is important that countries ensure high vaccination coverage and close immunity gaps, to avoid risk of future outbreaks.
从 2020 年 1 月到 2022 年 7 月,意大利国家监测系统共报告了 120 例麻疹病例,其中 105 例于 2020 年发病,9 例于 2021 年发病,6 例于 2022 年前 7 个月发病。与 COVID-19 大流行之前的时期相比,这一数字急剧下降,很可能是由于为防止 SARS-CoV2 传播而实施的非药物干预措施。2020 年报告的 105 例病例中,有 103 例是在 2020 年 3 月 9 日实施全国封锁之前感染的。总体而言,报告的病例中有四分之一至少出现一种并发症。随着全球非药物大流行措施的放松,并且考虑到麻疹的季节性、传染性及其潜在严重性,各国确保高疫苗接种覆盖率并缩小免疫差距以避免未来暴发的风险非常重要。